Psychedelic Capital

March 2022

March 24, 2022

Microdose's Psychedelic Capital: March 2022 hosted Clearmind Medicine. Featuring Mark Haden, Dr. Adi Zuloff-Shani. Access the recording here:


Adjunct Prof. Mark Haden

Clearmind's VP of Business Development

Previously the Executive Director of MAPS Canada for 10 years, Mark is an adjunct professor at the University of British Columbia's School of Population and Public Health, and has published on the issue of drug control policy and psychedelics. Mark also worked in the addictions field in counselling, supervisory and management positions for 28 years.

Adi Zuloff-Shani, PhD

Clearmind's Chief Executive Officer

Dr. Adi Zuloff-Shani is a biomedical research and development executive with over 20 years of strategic and operational leadership in the healthcare industry, and a deep understanding of therapeutics development in heavily regulated environments.


Patrick Moher

Microdose President

Microdose President